Concepedia

Publication | Closed Access

Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma

DOI

61

Citations

26

References

2005

Year

Chuan-Cheng Wang, Jang‐Yang Chang, Tsang-Wu Liu, Chin‐Yu Lin, Yu-Chieh Yu, Ruey‐Long Hong
Head & Neck

Abstract

Given the moderately high activity and favorable toxicity profile, GV is a reasonable choice for patients with cisplatin-resistant NPC.

References

YearCitations

Page 1